PHARMA PROJECT
ActiveSummary
PHARMA PROJECT has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€33,296) and a net result of -€11,278. Equity is shrinking by ~47% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability44▼-5
Solvency21▼-1
Growth58=
Track record100
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.03 against 0.0 in 2024; short-term debt: 59.5% and cash: 1.5% of total assets), and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-4.1%
Return on assets
-1.4%
Age of the figures
15 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year -€33,296
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 05-01-2026, 26 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
26 d early
2024
57 d early
2023
56 d early
2022
63 d early
2021
53 d early
2020
177 d late
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 11 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 6 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
-€33,296▼ 51.2%
2024 · -€22,018
Total assets
€806,013▼ 6.6%
2024 · €862,958
Net result
-€11,278
2024 · €1,627
Working capital
-€465,199▼ 10.7%
2024 · -€420,411
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€28,394€19,256▼ 32.2%€15,080▼ 21.7%€28,632▲ 89.9%€14,333▼ 49.9%
Net result-€5,237▲ 92.4%-€11,819▼ 126%-€13,986▼ 18.3%€1,627-€11,278
Equity€2,160▼ 70.8%-€9,659-€23,645▼ 145%-€22,018▲ 6.9%-€33,296▼ 51.2%
Total assets€1.1m▼ 7.2%€1.0m▼ 6.4%€936,311▼ 7.5%€862,958▼ 7.8%€806,013▼ 6.6%
Debt€1.1m▼ 6.8%€1.0m▼ 5.4%€959,956▼ 6.1%€884,976▼ 7.8%€839,308▼ 5.2%
Working capital-€309,551▼ 6.6%-€351,349▼ 13.5%-€391,841▼ 11.5%-€420,411▼ 7.3%-€465,199▼ 10.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 50% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €806,013
Fixed assets
€791,764 ▼ 8.1%
Current assets
€14,248 ▲ 809%
Key figures and ratios
EBITDA
€83,959▼
2024 · €98,259
Cash flow
€58,348▼
2024 · €71,253
Solvency
-4.1%▼
2024 · -2.6%
Current ratio
0.03▲
2024 · 0.00
Debt to equity
-25.21▲
2024 · -40.19
ROA
-1.4%▼
2024 · 0.2%
Interest coverage
3.28▼
2024 · 3.64
Debt ≤ 1 year
€479,447▲
2024 · €421,979
Debt > 1 year
€358,771▼
2024 · €461,661
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,242 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 93% are still going.
- Small
- 20 years or older
- negative equity
- a small loss
1.6%
went bankrupt
3.8%
stopped otherwise
93%
still going
A further 1.9% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.0% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,242 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €77,763 | €74,947 | €74,218 | €69,626 | €69,626 | = |
| Gross operating margin9900 | €106,157 | €94,202 | €89,298 | €98,259 | €83,959 | ▼ 14.6% |
| Operating profit (loss)9901 | €28,394 | €19,256 | €15,080 | €28,632 | €14,333 | ▼ 49.9% |
| Financial charges65/66B | - | €31,074 | €29,066 | €27,005 | €25,611 | ▼ 5.2% |
| Recurring financial charges65 | €33,631 | €31,074 | €29,066 | €27,005 | €25,611 | ▼ 5.2% |
| Profit (loss) for the period before taxes9903 | -€5,237 | -€11,819 | -€13,986 | €1,627 | -€11,278 | ▼ 793% |
| Profit (loss) for the period9904 | -€5,237 | -€11,819 | -€13,986 | €1,627 | -€11,278 | ▼ 793% |
| Profit (loss) for the period to be appropriated9905 | -€5,237 | -€11,819 | -€13,986 | €1,627 | -€11,278 | ▼ 793% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.1m | €1.0m | €936,311 | €862,958 | €806,013 | ▼ 6.6% |
| Fixed assets21/28 | €1.1m | €1.0m | €931,017 | €861,391 | €791,764 | ▼ 8.1% |
| Tangible fixed assets22/27 | €1.1m | €1.0m | €931,017 | €861,391 | €791,764 | ▼ 8.1% |
| Land and buildings22 | - | €208,073 | €203,213 | €198,353 | €193,493 | ▼ 2.5% |
| Furniture and vehicles24 | - | €5,227 | €4,182 | €3,136 | €2,091 | ▼ 33.3% |
| Leasing and similar rights25 | - | €791,935 | €723,623 | €659,902 | €596,181 | ▼ 9.7% |
| Current assets29/58 | €1,776 | €6,968 | €5,294 | €1,568 | €14,248 | ▲ 809% |
| Cash at bank and in hand54/58 | - | €4,983 | €3,079 | - | €11,865 | - |
| Deferred charges and accrued income490/1 | - | €1,985 | €2,215 | €1,568 | €2,383 | ▲ 52.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.1m | €1.0m | €936,311 | €862,958 | €806,013 | ▼ 6.6% |
| Equity10/15 | €2,160 | -€9,659 | -€23,645 | -€22,018 | -€33,296 | ▼ 51.2% |
| Contributions10/11 | €62,000 | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Capital10 | - | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Issued capital100 | - | €62,000 | €62,000 | €62,000 | €62,000 | = |
| Revaluation surpluses12 | - | €743,886 | €743,886 | €743,886 | €743,886 | = |
| Profit (loss) carried forward14 | -€803,726 | -€815,545 | -€829,531 | -€827,904 | -€839,182 | ▼ 1.4% |
| Amounts payable17/49 | €1.1m | €1.0m | €959,956 | €884,976 | €839,308 | ▼ 5.2% |
| Amounts payable after more than one year17 | €755,007 | €657,535 | €557,040 | €461,661 | €358,771 | ▼ 22.3% |
| Financial debts170/4 | - | €657,535 | €557,040 | €461,661 | €358,771 | ▼ 22.3% |
| Amounts payable within one year42/48 | €311,327 | €358,317 | €397,135 | €421,979 | €479,447 | ▲ 13.6% |
| Current portion of amounts payable after more than one year42 | - | €105,015 | €108,266 | €103,388 | €102,889 | ▼ 0.5% |
| Financial debts43 | - | - | - | €20,386 | - | - |
| Credit institutions430/8 | - | - | - | €20,386 | - | - |
| Trade debts44 | - | €2,245 | €2,540 | €1,651 | €9,878 | ▲ 498% |
| Suppliers440/4 | - | €2,245 | €2,540 | €1,651 | €9,878 | ▲ 498% |
| Taxes, remuneration and social security45 | - | €757 | €909 | €1,060 | €1,492 | ▲ 40.7% |
| Taxes450/3 | - | €757 | €909 | €1,060 | €1,492 | ▲ 40.7% |
| Other amounts payable47/48 | - | €250,300 | €285,420 | €295,494 | €365,188 | ▲ 23.6% |
| Accrued charges and deferred income492/3 | - | €6,010 | €5,781 | €1,337 | €1,090 | ▼ 18.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€5,237 | -€11,819 | -€13,986 | €1,627 | -€11,278 | ▼ 793% |
| + Depreciation and write-downs630 | €77,763 | €74,947 | €74,218 | €69,626 | €69,626 | = |
| Operating cash flow (approximation) | €72,525 | €63,128 | €60,232 | €71,253 | €58,348 | ▼ 18.1% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | - | -€1,904 | - | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
05-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2024
05-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
30-06
Financial
Back to profitnet €1,627
Net result €1,627 after 5 loss-making years.
2023
06-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
29-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
09-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
27-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 177 days late
2020
30-06
Financial
Weakest financial yearnet -€68,953
Net result drops to -€68,953, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2018
20-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
11-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2016
25-11
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 1996
Ground area
274 m²
Building footprint
124 m²
Volume, LiDAR
1,350 m³
Parcel 25112M0335/00E000, Wallonia · tallest building 15.9 m, ±4 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 establishment unit
PHARMA PROJECT
since 19962.079.468.974
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25112M0335/00E000 | Wallonia | 273 m² | 1 · 124 m² | 15.9 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Identification & contact
Identification
Legal formPublic limited company
Founded19-06-1996
Fiscal year end30-06
E-invoicing
Reachable via Peppol
Peppol ID
0208:0458257001
Also
9925:BE0458257001
Registered
04-05-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.